Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-invasive biomarkers for chronic hepatitis B virus infection management
Caroline Charre, Massimo Levrero, Fabien Zoulim, et al.
Antiviral Research (2019) Vol. 169, pp. 104553-104553
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Covalently closed circular DNA: The ultimate therapeutic target for curing HBV infections
María Guadalupe Martínez, Anders Boyd, Emmanuel Combe, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 3, pp. 706-717
Open Access | Times Cited: 111
The scientific basis of combination therapy for chronic hepatitis B functional cure
Seng Gee Lim, Thomas F. Baumert, Carolina Boni, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 4, pp. 238-253
Open Access | Times Cited: 96
The times they are a-changing – A refined proposal for finite HBV nucleos(t)ide analogue therapy
Thomas Berg, Pietro Lampertico
Journal of Hepatology (2021) Vol. 75, Iss. 2, pp. 474-480
Closed Access | Times Cited: 58
The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis
Shivani Singh, Simon Boyd, William HK Schilling, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 5, pp. 935-945
Open Access | Times Cited: 10
Overrange dilution for improvement of hepatitis B core related antigen as a biomarker: protocol validation and examples for application
Maria Pfefferkorn, Jessica H. Brehm, Martin Brehm, et al.
Virology (2025) Vol. 609, pp. 110576-110576
Open Access | Times Cited: 1
Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management
Alicia Vachon, Carla Osiowy
Viruses (2021) Vol. 13, Iss. 6, pp. 951-951
Open Access | Times Cited: 48
Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B
Barbara Testoni, Caroline Scholtès, Marie‐Laure Plissonnier, et al.
Gut (2023) Vol. 73, Iss. 4, pp. 659-667
Open Access | Times Cited: 22
Performance of the cobas® HBV RNA automated investigational assay for the detection and quantification of circulating HBV RNA in chronic HBV patients
Caroline Scholtès, Aaron T. Hamilton, Marie‐Laure Plissonnier, et al.
Journal of Clinical Virology (2022) Vol. 150-151, pp. 105150-105150
Open Access | Times Cited: 25
Clinical Utility of Quantitative HBV Core Antibodies for Solving Diagnostic Dilemmas
Ivana Lazarević, Ana Banko, Danijela Miljanovic, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 373-373
Open Access | Times Cited: 14
Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study
Minseok Albert Kim, Seung Up Kim, Dong Hyun Sinn, et al.
Gut (2020) Vol. 69, Iss. 12, pp. 2214-2222
Closed Access | Times Cited: 34
Rapid Diagnostics for Hepatitis B and C Viruses in Low- and Middle-Income Countries
Juliet Adamma Shenge, Carla Osiowy
Frontiers in Virology (2021) Vol. 1
Open Access | Times Cited: 27
A critique and systematic review of the clinical utility of hepatitis B core-related antigen
Celina Adraneda, Yong Chuan Tan, Ee Jin Yeo, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 4, pp. 731-741
Closed Access | Times Cited: 19
Abnormal collagen deposition mediated by cartilage oligomeric matrix protein in the pathogenesis of oral submucous fibrosis
Yafei Xiong, Xuechun Li, Bincan Sun, et al.
International Journal of Oral Science (2025) Vol. 17, Iss. 1
Open Access
HBsAg Isoforms as Innovative Biomarkers in Predicting Virological Response to Bulevirtide in Patients With Chronic Hepatitis D
Stefano D’Anna, Romina Salpini, Elisabetta Degasperi, et al.
Liver International (2025) Vol. 45, Iss. 5
Closed Access
Uncovering the Anticancer Mechanisms of Chinese Herbal Medicine Formulas: Therapeutic Alternatives for Liver Cancer
Feiyu Chen, Zhangfeng Zhong, Hor‐Yue Tan, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 25
Rapid screening of hepatitis B using Raman spectroscopy and long short-term memory neural network
Xin Wang, Shengwei Tian, Long Yu, et al.
Lasers in Medical Science (2020) Vol. 35, Iss. 8, pp. 1791-1799
Closed Access | Times Cited: 25
Functional Cure of Hepatitis B Virus Infection in Individuals With HIV-Coinfection: A Literature Review
Anders Boyd, Lorenza N C Dezanet, Karine Lacombe
Viruses (2021) Vol. 13, Iss. 7, pp. 1341-1341
Open Access | Times Cited: 19
Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis
Gian Paolo Caviglia, Angelo Armandi, Chiara Rosso, et al.
Diagnostics (2021) Vol. 11, Iss. 2, pp. 187-187
Open Access | Times Cited: 15
An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression
Giuseppina Brancaccio, Romina Salpini, Lorenzo Piermatteo, et al.
Microorganisms (2021) Vol. 9, Iss. 4, pp. 752-752
Open Access | Times Cited: 12
Hepatitis B virus serum RNA transcript isoform composition and proportion in chronic hepatitis B patients by nanopore long-read sequencing
Alicia Vachon, G. Seo, Nishi H. Patel, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 5
A molecular standard for circulating HBV RNA detection and quantification assays in chronic hepatitis B patients
Alexia Paturel, Francesca Casuscelli di Tocco, Delphine Bousquet, et al.
JHEP Reports (2024) Vol. 6, Iss. 10, pp. 101124-101124
Open Access | Times Cited: 1
Cryptic HBV Replicative Activity Is Frequently Revealed in Anti-HBc-Positive/HBsAg-Negative Patients with HIV Infection by Highly Sensitive Molecular Assays, and Can Be Predicted by Integrating Classical and Novel Serological HBV Markers
Romina Salpini, Vincenzo Malagnino, Lorenzo Piermatteo, et al.
Microorganisms (2020) Vol. 8, Iss. 11, pp. 1819-1819
Open Access | Times Cited: 10
Editorial: The role of novel hepatitis B biomarkers in solving therapeutic dilemmas
Ivana Lazarević, Valentina Svicher, Maja Ćupić
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Biomarkers for hepatitis B virus replication: an overview and a look to the future
Fengcai Li, Yuekai Li, Yu‐Chen Fan
Expert Review of Gastroenterology & Hepatology (2020) Vol. 14, Iss. 12, pp. 1131-1139
Closed Access | Times Cited: 8
Special Issue: “Updates on HBV Infection”
Isabelle Chemin, Flor H. Pujol
Microorganisms (2022) Vol. 10, Iss. 3, pp. 580-580
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top